Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04546009
Brief Title: A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)

First Submitted : September 8, 2020
First Submitted that Met QC Criteria : September 8, 2020
First Posted : September 11, 2020

Last Update Submitted that Met QC Criteria : April 6, 2021
Last Update Posted : April 8, 2021